DB 2306
Alternative Names: DB-2306Latest Information Update: 04 Jan 2023
At a glance
- Originator Duality Biologics
- Class Antibodies; Drug conjugates; Immunoconjugates
- Mechanism of Action Glucocorticoid receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Autoimmune disorders
Most Recent Events
- 10 Nov 2022 Pharmacodynamics and adverse events data from a preclinical trial in Autoimmune disorders (Parenteral) presented at the American College of Rheumatology convergence 2022 (ACR-2022)
- 12 Oct 2022 Preclinical trials in Autoimmune disorders in China (Parenteral) (Duality Biologics pipeline, October 2022)